Review Article
Volume 5 Issue 4 - 2021
Kidney Disease Management during the COVID-19 Pandemic
Yin-Hong Geng1, Zhe Zhang1, Xiao-Li Pan2 and Ya-Fei Liu1*
1Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
2College of Acupuncture and Orthopedics, Hubei University of Chinese Medicine, Wuhan, Hubei, China
*Corresponding Author: Ya-Fei Liu, Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Received: March 31, 2021; Published: April 02, 2021


The aim of the study was to summarize the kidney disease management–related literature during the unprecedented COVID-19 pandemic to attract clinicians’ attention to strengthen kidney disease management. The patients were divided into six groups according to non-dialysis or dialysis, diagnosis with COVID-19 or without COVID-19. Kidney transplant patients were also included in the study. The agents commonly administrated by kidney disease patients such as corticosteroids, immunosuppressants, angiotensin-converting enzyme inhibitor/angiotensin-receptor blocker, chloroquine/hydroxychloroquine were also analyzed for their weaknesses and strengths during the COVID-19 pandemic. In addition, the risk and challenges that these patients faced were summarized and recommendations were given for clinicians and patients with kidney diseases to better manage kidney disease during the COVID-19.

Keywords: Kidney Disease; Management; COVID-19; Pandemic


  1. Wang Yixuan., et al. “Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures”. Journal of Medical Virology6 (2020): 568-576.
  2. Yan Renhong., et al. “Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2”. Science (New York, N.Y.)6485 (2020): 1444-1448.
  3. Ye Minghao., et al. “Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes”. Journal of the American Society of Nephrology: JASN11 (2006): 3067-3075.
  4. Diao B., et al. “Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection”. medrxiv (2020).
  5. Emami Amir., et al. “Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis”. Archives of Academic Emergency Medicine1 (2020): e35.
  6. Ji Hong-Long., et al. “Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility”. Physiological Reviews3 (2020): 1065-1075.
  7. Lin Jiangtao., et al. “Several problems of glucocorticoid application in the treatment of SARS”. Chinese Journal of Tuberculosis and Respiration6 (2003): 326-327.
  8. Shen Qian., et al. “Consensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic”. Pediatric Nephrology (Berlin, Germany)7 (2020): 1351-1357.
  9. Dawei Wang., et al. “Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China”. JAMA11 (2020): 1061-1069.
  10. Gao Jianjun., et al. “Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies”. Bioscience Trends1 (2020): 72-73.
  11. Zhao Jianping., et al. "New Coronavirus pneumonia corticosteroid use recommendations”. Chinese Journal of Tuberculosis and Respiratory Medicine 3 (2020): 183-184.
  12. "Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected” (2020).
  13. Russell Clark D., et al. “Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury”. Lancet (London, England)10223 (2020): 473-475.
  14. Shang Lianhan., et al. “On the use of corticosteroids for 2019-nCoV pneumonia”. Lancet (London, England)10225 (2020): 683-684.
  15. Wu Chaomin., et al. “Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China”. JAMA Internal Medicine7 (2020): 934-943.
  16. Han Yuanyuan., et al. “COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster”. Clinical Immunology (Orlando, Fla.) 214 (2020): 108413.
  17. Tian Lu., et al. “Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors”. Chinese Journal of Biotechnology4 (2020): 605-611.
  18. Softic Laurent., et al. “Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025)”. Antimicrobial Agents and Chemotherapy7 (2020): e00876-20.
  19. de Wilde Adriaan H., et al. “Cyclosporin A inhibits the replication of diverse coronaviruses”. The Journal of General Virology11 (2011): 2542-2548.
  20. Carbajo-Lozoya Javier., et al. “Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506”. Virus Research 1 (2012): 112-117.
  21. Willicombe Michelle., et al. “COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?”. Journal of the American Society of Nephrology: JASN6 (2020): 1145-1146.
  22. South Andrew M., et al. “Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic”. Nature Reviews. Nephrology6 (2020): 305-307.
  23. Meng Juan., et al. “Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension”. Emerging Microbes and Infections1 (2020): 757-760.
  24. Bean Daniel M., et al. “Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust”. European Journal of Heart Failure 22,6 (2020): 967-974.
  25. Liu Y., et al. “Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients”. medRxiv (2020).
  26. Sriram Krishna and Paul A Insel. “Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence”. Clinical Pharmacology and Therapeutics2 (2020): 236-241.
  27. Savarino Andrea., et al. “Effects of chloroquine on viral infections: an old drug against today's diseases?”. The Lancet Infectious Diseases11 (2003): 722-727.
  28. Devaux Christian A., et al. “New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?”. International Journal of Antimicrobial Agents5 (2020): 105938.
  29. Alberici Federico., et al. “Management Of Patients On Dialysis And With Kidney Transplant During SARS-COV-2 (COVID-19) Pandemic In Brescia, Italy”. Kidney International Reports (2020).
  30. Gleeson Shana E., et al. “Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic”. Clinical journal of the American Society of Nephrology: CJASN6 (2020): 892-895.
  31. Guillen Elena., et al. “Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?”. American Journal of Transplantation 20.7 (2020): 1875-1878.
  32. Man Zhang., et al. “Viral shedding prolongation in a kidney transplant patient with COVID-19 pneumonia”. American Journal of Transplantation9 (2020): 2626-2627.
  33. Wang Junpeng., et al. “COVID-19 in a Kidney Transplant Patient”. European Urology6 (2020): 769-770.
  34. Cheng Yichun., et al. “Kidney disease is associated with in-hospital death of patients with COVID-19”. Kidney International5 (2020): 829-838.
  35. Yang Xiang-Hong., et al. “Expert recommendations on blood purification treatment protocol for patients with severe COVID-19”. Chronic Diseases and Translational Medicine 2 (2020): 106-114.
Citation: Ya-Fei Liu., et al. “Kidney Disease Management during the COVID-19 Pandemic”. EC Diabetes and Metabolic Research 5.4 (2021): 13-19.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 21, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.